close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by PureTech Health plc

< Previous 1 2 3 4 5 6 Next >
News headline image
PureTech Founded Entity Akili Announces Positive Results from Shionogi’s Phase 3 Clinical Trial of Localized Version of Akili’s EndeavorRx ® for Pediatric ADHD Patients in Japan
From PureTech Health plc
Via Business Wire
Tickers AKLI PRTC
News headline image
PureTech to Present at 42nd Annual J.P. Morgan Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Karuna Therapeutics to be Acquired by Bristol Myers Squibb for $14 Billion
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Year End Update and Outlook for 2024
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Presents Data from Phase 1 Trial of LYT-200 Targeting Galectin-9 in Solid Tumors at the ESMO Immuno-Oncology Congress 2023
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia
From PureTech Health plc
Via Business Wire
Tickers KRTX PRTC
News headline image
PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech to Present at Two Upcoming Investor Conferences
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Vedanta Biosciences Announces First Patient Dosed in Phase 2 Clinical Trial of VE202 for the Treatment of Ulcerative Colitis and Receives Fast Track Designation
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
KarXT, invented at PureTech, submitted for FDA Approval in Schizophrenia
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Health plc – Half-Year Report
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Health: Notice of Half-Yearly Results
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Initiates Phase 2a Clinical Trial of LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
Results of PureTech's Annual General Meeting
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech to Present at the Jefferies Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Vedanta Biosciences Receives Fast Track Designation for VE303 and Presents Phase 2 Data at Digestive Disease Week
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Akili Announces Adults with ADHD See Significant Improvements in Attention, ADHD Symptoms, and Quality of Life in Clinical Trial of Akili’s EndeavorRx® Video Game-Based Therapeutic
From PureTech Health plc
Via Business Wire
Tickers AKLI PRTC
News headline image
PureTech Announces Annual Results for Year Ended December 31, 2022
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Vedanta Biosciences Announces $106.5 Million Financing to Advance Pipeline of Defined Bacterial Consortia Therapies
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Vedanta Biosciences Publishes Phase 2 Results in the Journal of the American Medical Association and Presents at ECCMID
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Health: Notice of Results
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
From PureTech Health plc
Via Business Wire
Tickers PRTC RPRX
News headline image
PureTech to Present at the Barclays Global Healthcare Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech Founded Entity Sonde Health and Massachusetts General Hospital Selected for National Institute on Aging Study to Examine Use of Voice in Remote Detection and Monitoring of Mild Cognitive Impairment Including Frontotemporal Disorders (FTD)
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech to Advance LYT-300 (Oral Allopregnanolone) for the Potential Treatment of Anxiety Disorders and Postpartum Depression
From PureTech Health plc
Via Business Wire
Tickers PRTC
News headline image
PureTech to Present at the SVB Securities Global Biopharma Conference
From PureTech Health plc
Via Business Wire
Tickers PRTC
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.